Skip to main content
. 2006 Aug 23;62(1):36–42. doi: 10.1136/thx.2006.059410

graphic file with name tx59410.f4.jpg

Figure 4 (A) Circulating and (B) alveolar neutrophil adhesion molecule (CD11b, CD18 and CD49) and activation maker (CD64) expression in normal volunteers and patients with acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) at baseline and after 4 days of treatment with intravenous salbutamol. Data shown are mean (SE).